Ocuphire Pharma, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2012

Schedule Of Assets And Liabilities Measured At Fair Value On A Recurring Basis


	Fair Value Measurements at September 30, 2012
	Total		Level 1		Level 2		Level 3
Assets:
Restricted Cash equivalents	$	217,173	$	179,673	$	37,500	$	-
Marketable Securities		100,000		100,000		-		-
Total Assets:	$	317,173	$	279,673	$	37,500	$	-

Liabilities:
Warrant Liabilities	$	1,524,270		-		-	$	1,524,270



	Fair Value Measurements at December 31, 2011
	Total		Level 1		Level 2		Level 3
Assets:
Restricted Cash equivalents	$	1,431,765	$	1,394,265	$	37,500	$	-
Marketable Securities		1,950,000		1,950,000		-		-
Total Assets:	$	3,381,765	$	3,344,265	$	37,500	$	-

Liabilities:
Warrant Liabilities	$	868,725		-		-	$	868,725

Reconciliation Of Changes In The Fair Value Of Liabilities


	Warrant Liabilities		Total Level 3 Liabilities
Balance at January 1, 2012	$	868,725	$	868,725
Additions		-		-
Unrealized losses, net		655,545		655,545
Unrealized gains on expiration		-		-
Transfers out of level 3		-		-
Balance at September 30, 2012	$	1,524,270	$	1,524,270



	Warrant Liabilities		Total Level 3 Liabilities
Balance at January 1, 2011	$	2,966,710	$	2,966,710
Additions		2,924,333		2,924,333
Unrealized gains, net		(1,954,900)		(1,954,900)
Unrealized gains on expiration		(38,569)		(38,569)
Transfers out of level 3		(243,868)		(243,868)
Balance at September 30, 2011	$	3,653,706	$	3,653,706

- Definition

Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.

+ References + Details